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Abstract 
The increase in the prevalence of obesity and gastroesophageal reflux disease (GERD) has paralleled one another. 
Laparoscopic fundoplication (LF) (Nissen or Toupet) is a minimally invasive form of anti-reflux surgery. The duodenal 
switch is a highly effective weight loss surgery with a proven record of long term weight loss success. However, fun-
doplication alone does not give satisfactory results when used for GERD in morbidly obese patients. Here we present 
a novel approach combining stomach intestinal pylorus sparing surgery (SIPS) with LF for morbidly obese patients 
with GERD. The data from patients who underwent the SIPS procedure along with LF in past year was retrospectively 
analyzed. The variables collected were age, sex, height, weight, intra-operative and post-operative complications, 
length of stay, operative time, and estimated blood loss. All revisions were excluded. Descriptive statistics such as 
mean and standard deviation were used to analyze the data. The total sample size of the study was 5 patients, with a 
mean age of 59.6 ± 16.4 years, a mean weight of 292.1 ± 73.6 lbs., and a mean body mass index (BMI) of 43.4 ± 6.3. 
Weight loss patterns were the same as those without LF. All the 5 patients had resolution or improvement in their 
GERD symptoms within 6 months. SIPS with LF provides substantial and sustained weight loss and GERD resolution. 
Long term follow ups and further study on this novel surgical technique is recommended.
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Background
Morbid obesity is a chronic disease which leads to pro-
gressive co-morbidities, socio-economic problems, 
undesirable quality of life, and earlier death. To date 
only metabolic/bariatric surgeries have achieved signifi-
cant weight loss, with the corresponding correction or 
improvement of co-morbidities, improving quality of 
life. Duodenal switch (DS) is one of the most efficacious 
forms of bariatric surgical therapy for the morbidly obese 
available to the clinician (Hess et al. 2005; Buchwald et al. 
2004).
Gastroesophageal reflux disease (GERD) is a common 
comorbidity associated with obesity (Hampel et al. 2005). 
However, laparoscopic fundoplication (LF) does not give 
satisfactory results in treatment for GERD in morbidly 
obese patients since obesity predisposes the patient to 
high rates of LF failure (Antanavicius et al. 2008; Makris 
et al. 2009).
We report a novel technique involving both LF and a 
modification of the DS called SIPS (stomach and intes-
tinal pyloric sparing surgery) which together provide 
optimal weight loss and optimal anti-reflux characteris-
tics while limiting complications associated with another 
common weight loss intervention for GERD in the set-
ting of morbid obesity(the laparoscopic gastric bypass 
[LRYGBP]).
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Method
This is a retrospective analysis of the initial experience 
from a single surgeon at single institution. The primary 
objective of this study was to evaluate the SIPS procedure 
along with LF in terms of weight loss, operative compli-
cations, and GERD resolution.
Each patient had a thorough work up for morbid obe-
sity and GERD. All the patients were experiencing GERD 
symptoms before surgery, and underwent esophagogas-
troduodenoscopy (EGD) and a transnasal endoscopy 
(TNE) to assess GERD symptoms and erosive esophagi-
tis (EE). Two patients had a Bravo pH study and manom-
etry to asses for esophageal dysmotility and to confirm 
the diagnosis of GERD. The other three patients had 
giant hiatal hernias on endoscopy with erosive esophagi-
tis. Therefore, we did not do pH studies or manometry 
as those diagnostic tests don’t work well in the setting of 
giant hiatal hernias. Additionally, erosive esophagitis is a 
clear indicator of GERD invalidating the need for pH stud-
ies. All patients were required to provide written informed 
consent for both the fundoplication and the SIPS proce-
dure before undergoing surgery. All the procedures were 
performed using a laparoscopic approach. Each patient 
had a post-operative upper gastro-intestinal (UGI) series 
prior to leaving the hospital to assess for leaks and obstruc-
tions and the adequacy of the wrap. All patients were seen 
back in clinic for follow up at 1 week, 1 month, 3 months, 
6 months, and 1 year. The GERD-HRQL questionnaire was 
used to assess typical symptoms of GERD.
Descriptive statistics were used to calculate the mean 
and standard deviation of pre-operative characteristics 
such as age, weight, height, and BMI. Procedure time was 
gathered and started with the first incision and ended 
with the dressing.
Our research was carried out according to our institu-
tions guidelines and the permission was granted to us to 
assess the patient’s data.
Surgical technique
Each case begins with placement of four trocars and a 
liver retractor. Next the short gastric vessels are taken 
down. This facilitates the dissection of the paraesopha-
geal hernia repair. The entire sac is removed using 
blunt and sharp dissection using an ultrasonixs dissec-
tor (Covidien LLC). This dissection is carried superiorly 
until approximately 5  cm of intra-abdominal length is 
achieved. The hernias are all repaired posterior to the 
esophagus with a two layer running technique with an 
endostich and 2.0 surgidac sutures. The first layer is a 
deep layer that starts where the crus meets inferiorly and 
goes up to the base of the esophagus. Once the esophagus 
is reached and we check to make sure there is no anterior 
defect, the suture line is run down back to the starting 
point and tied to the end of the stitch. This repair is rein-
forced with a PTFE felt mesh or Pariatex mesh (Covidien 
Corp.). Then a 40 French Bougie is placed. Depending on 
the patient, the wrap is created in a fashion described by 
Toupet or Nissen.
Next a Sleeve Gastrectomy is performed. The lesser sac 
is entered 4–6 cm from the pylorus. Then an Endo GIA 
(Covidien) stapler is fired along the previously placed siz-
ing tube. Once the staple line reaches the prior LF, the 
staple line deviates laterally attempting to resect as much 
of the fundus as possible. Blood vessels to the lesser curve 
are persevered ensuring adequate blood supply.
The next step is to divide the duodenal bulb. This is 
done by taking down all the gastro-epiploic vessels from 
the end of the sleeve dissection to past the pylorus. A 
band passer is then placed towards the liver under the 
duodenum, and a window is made through the duodenal-
hepatic ligament. Once the window is created, an Endo 
GIA (Covidien) stapler is passed around the duodenum 
and divides the duodenum 3  cm from the pylorus cir-
cumferentially. The distal duodenal stump is then sewn 
over with absorbable suture.
Next the ileo-cecal valve is located and traced retro-
grade to 300 cm, and that point is brought up and sewn 
to the proximal duodenal staple line. The loop limb is 
sewn to the proximal duodenal stump using 2.0 Polysorb 
(Covidien). Enterotomies are made in both the limbs 
and 3.0 Polysorb is used to do another posterior row and 
anterior row (Fig. 1).
The anastomoses are tested intra-operatively with pres-
surized air to check for leaks. The resected portion of 
the stomach is taken out of the abdominal cavity. Anti-
biotics and deep vein thrombosis (DVT) prophylaxis are 
used in all patients. The patients are discharged the next 
day if they do not exhibit nausea, vomiting or any other 
discomfort.
Classification of erosive esophagitis
All patients receive preoperative endoscopic evaluation. 
The diagnosis and classification is based on Los Angeles 
(LA) classification (Lundell et al. 1999). Table 1 explains 
the classification.
Grading of the gastroesophageal valve
Endoscopic grading of the gastroesophageal valve pro-
vides useful information about the reflux status (Öberg 
et al. 1999). To evaluate the same, we use the Hill Valve 
Grading Scheme (Hill et  al. 1996). The geometry of the 
gastroesophageal valve is assessed with the endoscope in 
the retroflexed position. The presence and appearance of 
the gastroesophageal flap valve is graded as I through IV.
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Grade I gastroesophageal valve—defined by the pres-
ence of a prominent fold of tissue closely approximated 
to the shaft of the endoscope and extending 3–4  cm 
along the lesser curve at the entrance of the esophagus 
into the stomach.
Grade II gastroesophageal valve—The fold of tissue 
is less prominent, and there are occasional periods of 
opening and rapid closing around the endoscope with 
respiration.
Grade III gastroesophageal valve—There is no promi-
nent fold at the entrance of the esophagus into the stom-
ach, and the endoscope is not tightly gripped by the 
tissues.
Grade IV gastroesophageal valve—The patient has 
a large hiatal hernia and essentially no fold where the 
lumen of the esophagus is gaping open, allowing the 
squamous epithelium to be viewed from below.
Measurement of reflux symptoms
The GERD-Health Related Quality of Life Question-
naire (GERD-HRQL) is a self-assessed, reliable, valid, 
responsive, and practical measure of symptom severity in 
patients with GERD (Velanovich et  al. 1996; Velanovich 
2007). It’s a 10-item questionnaire with an assessment of 
overall satisfaction. Items are scored on a 6 point scale 
(0–5), addressing domains like heartburn (Items 1–6), 
dysphagia (item 7), odynophagia (item 8), meteorism 
(item 9), effect of medications (item 10), and satisfaction 
level. But no extra-esophageal symptoms are included. It 
is evaluated post operatively at 6 months and 1 year. The 
heartburn score is calculated by summing the individual 
score to questions 1–6, with score of 30 being the worst 
heartburn and score of 0 being no heartburn. Any score of 
≤12 with each individual question not exceeding 2 indi-
cates heartburn elimination. The total score is calculated 
by summing the individual scores to questions 1–10, with 
greatest possible score of 50 (worst symptoms) and lowest 
possible score of 0 (no symptoms) (Hunter et al. 1996).
Results
We analyzed a total of 5 patients aged between 
18-85 years. The pre-operative characteristics are shown 
in Table 2. The mean operative time overall was 115 min. 
The mean estimated blood loss was 35  cc. The mean 
post-operative hospitalization stay was 2.4 ±  1.14  days. 
Two patients (40  %) had perioperative complications. 
One patient had an ileus, while the other had low oxy-
gen saturation on day 2. However, both the complications 
were mild and patients recovered uneventfully. The first 
patient returned within 30 days of the surgery with nau-
sea, vomiting, diarrhea, and clostridium difficile colitis. 
Only one (20 %) reported dysphagia (Post op >30 days). 
Table 3 highlights operative outcomes.
Fig. 1 Diagrammatic representation of SIPS with Nissen Fundoplica-
tion
Table 1 Los Angeles classification for erosive esophagitis
Grade Definition
A ≥1 mucosal breaks ≤5 mm long, none of which extends 
between the tops of the mucosal folds
B ≥1 mucosal breaks >5 mm long, none of which extends 
between the tops of mucosal folds
C Mucosal breaks that extend between the tops of ≥2 mucosal 
folds, but which involve <75 % of the esophageal circumfer-
ence
D Mucosal breaks which involve ≥75 % of the esophageal 
circumference
Table 2 Preoperative characteristics
a Values are expressed as mean ± SD
No. of patients 5
Age (years)a 59.6 ± 16.4
Weight (lbs.)a 292.1 ± 73.6
Height (in)a 68.3 ± 4.2
BMIa 43.4 ± 6.3
Male 3
Female 2
Ideal Body Weight (lbs.)a 147.5 ± 26.1
Excess body Weight (lbs.)a 144.6 ± 51.5
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Weight loss analysis
Each patient’s weight loss mirrored our larger group of 
SIPS patient. Refer to Table 4 for complete analysis.
GERD analysis
Refer to Table  5 for complete pre-operative and post-
operative GERD analysis.
Table  6 summarizes the post-operative GERD-HRQL 
scale.
Discussion
The increasing prevalence of obesity worldwide has coin-
cided with an increasing prevalence of GERD (Hampel 
et al. 2005). Morbid obesity is a key risk factor for GERD 
partly because obesity increases the intra-abdominal 
pressure, generating the forces necessary to cause reflux 
(Hampel et al. 2005; Barak et al. 2002; Groot et al. 2009). 
Obese patients may have an increased risk for hiatal her-
nia, which has a role in initiating and promoting GERD 
(Kahrilas 1999). Although LF is not the only treatment 
modality for intractable GERD, it is the preferred method 
for most surgeons.
Several studies have suggested that Roux-en-Y gastric 
bypass is a more effective operation for GERD than Nis-
sen fundoplication in the morbidly obese GERD patients 
(Braghetto et al. 2012; Varela et al. 2009). While propo-
nents are correct to argue that LRYGBP does eliminate 
GERD in most patients and it is a successful weight loss 
Table 3 Post-op complications
Ileus 1
Low oxygen saturation 1
Nausea with Diarrhea (Clostridium Difficile Colitis) 1
Dysphagia requiring intervention 1
Readmission <30 days 1
Table 4 Weight loss analysis
a Values are expressed as mean ± SD
Months <3 months (n = 5) 3–6 months (n = 5) 7–12 months (n = 2) >12 months (n = 2)
Total body weight loss (lbs.)ª 42.1 ± 11.6 69.9 ± 30.1 86.5 ± 14.1 98.9 ± 13.1
Total body weight loss (%)ª 14.5 ± 2.3 23.4 ± 5.2 33.1 ± 0.2 38 ± 1.5
Excess weight loss (%)ª 29.9 ± 5.8 47.9 ± 8 73.5 ± 5.3 84.2 ± 3.4
BMI reduction (kg/m2)ª 6.3 ± 1.2 10.3 ± 3.5 13.2 ± 0.1 15.1 ± 0.4
Excess BMI loss (%)ª 35.8 ± 9.1 56.8 ± 11.5 89.1 ± 2.7 102.2 ± 6.4
Table 5 GERD analysis
HHR hiatal hernia repair, NF Nissen fundoplication









1 D IV 5 cm Sliding Hiatal 
Hernia
SIPS + HHR with 
Mesh + NF
0 Pre-operative Bravo PH study was posi-
tive for abnormal distal esophageal 
acid exposure
DeMeester score-105.5
2 A IV 8 cm Sliding Hiatal 
Hernia
SIPS + NF 19 Patient had history of esophageal dys-
motility syndrome
Post-operative manometry at 3 months 
showed poor esophageal dysmotility 
which was contributed to past history 
of motility disorder
3 C IV 5 cm Sliding Hiatal 
Hernia
SIPS + HHR with 
Mesh + NF
1 Pre-operative bravo pH study was posi-
tive for abnormal distal esophageal 
acid exposure
DeMeester score was 23.6
4 D IV 6 cm Sliding +huge 
paraesophageal 
hernia
SIPS + Paraesophageal 
Hernia Repair with 
Mesh + complete 
fundoplication
9
5 B II Huge paraesophageal 
Hernia
SIPS + Paraesophageal 
hernia repair with 
mesh + NF
2 Upper GI series at 6 months showed 
intake Nissan with no reflux
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operation, the gastric bypass surgery yields significant 
long term complications associated with the creation of 
the Roux limb such as ulcers, strictures, intussusceptions, 
dysfunctional Roux limb syndrome, internal hernias, 
slippage of the gastric pouch, and dumping syndrome. 
The SIPS with LF is not subject to these side effects (Ian-
nelli et al. 2006; Ledoux et al. 2014; Gasteyger et al. 2008; 
Zellmer et  al. 2014). Because of these side effects, Gas-
tric Bypass may not be an ideal operation for all morbidly 
obese GERD patients especially for patients who require 
long term NSAID therapy which is associated with bleed-
ing ulcers postoperatively.
Laparoscopic Sleeve Gastrectomy (SG) is one of the 
most commonly used Bariatric Surgeries. However, SG 
alone may cause or worsen GERD, as mentioned in the 
literature (Santoro et  al. 2014; Tai et  al. 2013; Peterson 
et al. 2012). Obesity itself also worsens GERD symptoms 
and causes fundoplication to fail. To achieve adequate 
weight loss and adequate GERD control in this patient 
population, we proposed combining two procedures that 
already provide good disease treatment for both disease 
processes present.
SIPS is a new technique that is a slight modification of 
the SADI (Single Anastomosis Duodenal-Ileal bypass) 
(Sanchz-Pernaute et  al. 2010). SIPS differs in that a 
smaller bougie is utilized, and intestinal length (3  m) is 
kept longer. The longer length along with the ileo-cecal 
valve helps reduce short bowel syndrome. The preser-
vation of the pylorus provides control of solid emptying 
reducing the chances of dumping syndrome and assist-
ing in maintaining a physiologic based rate of gastric 
emptying.
However the question that remains is whether this 
information is of importance to practicing bariatric 
surgeons and Gasto-surgeons for treating GERD in 
morbidly obese patients or whether another type of 
modification is necessary? This was answered recently 
by Khazzaka and Sarkis (2013) who reported fundoplica-
tion with gastric plication in 16 patients. Excess weight 
loss at 1 year was 10 kgs with resolution of GERD in all 
16 patients. Thereafter, surgeons from Taiwan published 
a paper on Nissen fundoplication with Gastric Plica-
tion (greater curvature side plication) in 25 patients 
with the excess weight loss of 24.6 kgs at 12  months 
(Lee et  al. 2014). However 8  % of their patients had a 
major complication post operatively. 21 patients out of 
25 had improvement with their GERD symptoms. With 
our technique we observed that our excess weight loss 
between 3 and 6 months was 69.980 lbs (31.81 kgs) and 
between 6 and 12  months, it was 86.50  lbs (39.32  kgs) 
which is more than both the studies with gastric 
plication.
Indeed a patient losing weight helps improve GERD, 
but there are some other theoretical explanations for 
this improvement that can occur before weight loss 
(Peterson et  al. 2012). By performing the SG as a first 
procedure of SIPS, we remove most oxyntic cells which 
reduces acid production. (Although it might be obvi-
ous, it has never been properly proved.) Even the faster 
rate of gastric emptying for liquids that is observed with 
sleeve helps in preventing and treating GERD. Addi-
tionally, we have data about the effect of LF on transient 
LES relaxations (TLESRs). Both partial (Lindeboom 
et  al. 2001) and Nissen Fundoplication (Staathof et  al. 
2001) reduces the occurrences of TLESRs. Thus com-
bining both the procedures, SIPS with LF, can be a feasi-
ble option for the treatment of GERD in morbidly obese 
patients.
The advantage of this novel technique as the treatment 
for both obesity and GERD is that the addition of malab-
sorption with the sleeve and the intestinal bypass make 
its weight loss more reliable than a sleeve alone, and this 
compensates for the larger volumes involved in making 
the LF.
This technique has not been previously discussed. All 
patients who underwent this combined procedure abso-
lutely did not want a gastric bypass because of its side 
effects and two were on chronic NSAID therapy. This 
approach, SIPS with LF, allowed the patients to pre-
serve the efficacy of the LF while maintaining the greater 
weight loss seen with SIPS (Hess et  al. 2005; Buchwald 
et al. 2004).
Table 6 Post-operative GERD-HRQL SCALE
Patients no. Heartburn  
Score (Q 1–6)






1 0 0 0 0 0 0 Satisfied
2 10 2 2 5 0 19 Satisfied
3 0 0 0 1 0 1 Satisfied
4 6 0 0 3 0 9 Satisfied
5 0 0 0 2 0 2 Satisfied
Mean 3.2 0.4 0.4 2.2 0 6.2 Satisfied
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The GERD-HRQL used here, has the advantage over 
standard health status instruments for GERD including 
simplicity for patients, high compliance rates, and the 
ease of understanding by physicians (Velanovich et  al. 
1996). Among the observed results of the GERD-HRQL 
questionnaire, questions 1–6 were related to heartburn, 
a typical symptom that affects patient’s quality of life. 
In this study, all our patients had a heartburn score of 
less than 12 with mean score of 3.2, which exhibits the 
elimination of their symptoms. Items 7–9 referred to 
symptoms of dysphagia, odynophagia, and meteorism 
considered side effects of the procedure. In this study 
these items were the main reason in raising the final 
score. However these symptoms are well tolerated by the 
patients and show improvement over time after the oper-
ation (Balci and Turkcapar 2007; Hamdy et al. 2008). Item 
10 was about the use of medication, and all of our patient 
reported 0 (no symptoms) to this question, revealing low 
or no need of medication and low impact on their qual-
ity of life. The last question of GERD-HRQL assessed the 
patient’s perception about their current health status into 
3 levels of satisfaction. It was noted that all of our patients 
marked satisfied and were between 6 and 12 months after 
the operation. It’s also worth mentioning that our mean 
total score was 6.2, with more than half of the patients 
having a total score below 5. Lower GERD-HRQL total 
scores indicated good quality of life, suggesting that sur-
gical treatment was effective. This modality is better than 
drug therapy when considering quality of life and patient 
satisfaction.
There are some limitations in this study. First is the 
small case number. This study is not meant to provide 
definitive superiority to LF or LRYGBP alone in the set-
ting of obesity but as a possibility in patients who both 
LF and LRYGBP are not options for various reasons. 
Consequently predicting its widespread applicability to 
all bariatric patients with reflux is premature and awaits 
larger trials. Secondly, we could not evaluate endoscopy 
or pH testing post-operatively in our patients, which is 
fundamental to evaluate the effect of anti-reflux surgery. 
Though we could get GERD-HRQL questionnaires for 
all our patients, we could not compare the data pre and 
post-surgery. However limited, the data does point to 
good quality of life following this surgery and this small 
study should be a stimulus to others in different centers 
to offer this option who have not considered it before.
According to our short-term follow up after SIPS with 
LF, we clearly demonstrate that it has effective early 
weight loss and a satisfactory anti-reflux effect.
Some may call this combined procedure experimen-
tal. However, our hospital surgical committee felt that 
since we were combining two known procedures, no 
IRB was needed. Additionally, the Blue Cross definition 
of experimental is any procedure where the outcome is 
unknown and in this case the two procedures outcomes 
are well known. The fact that we combined them doesn’t 
alter the effect of either one as we demonstrated.
Conclusion
In summary, our early results are encouraging. SIPS with 
LF, is a novel and technically feasible procedure that com-
bines fundoplication and bariatric surgery that can have 
good anti-reflux effects and substantial weight loss dur-
ing the short term follow up. Additional long term fol-
low ups and larger study populations would be required 
to further evaluate the outcomes of this novel technique 
to see if it is applicable to all bariatric GERD patients or 
should be reserved for special circumstances like we pre-
sented in this paper.
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